Mostrar el registro sencillo del ítem

dc.contributor.advisorMaia, Ana Luiza Silvapt_BR
dc.contributor.authorVargas, Carla Vaz Ferreirapt_BR
dc.date.accessioned2016-07-21T02:19:11Zpt_BR
dc.date.issued2013pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/143794pt_BR
dc.description.abstractMedullary thyroid carcinoma (MTC) is a rare malignant tumor originating from thyroid parafollicular C cells. This tumor accounts for 3-4% of thyroid gland neoplasias. MTC may occur sporadically or inherited. The hereditary MTC is part of syndromes of multiple endocrine neoplasia (MEN) 2A and 2B, familial medullary thyroid carcinoma (FMTC). Germline mutations of the RET (REarranged during Transfection) protooncogene cause hereditary form of cancer, whereas somatic mutations can be present in sporadic form of the disease. The RET gene encodes a receptor tyrosine kinase involved in the activation of intracellular signaling pathways leading to proliferation, growth, differentiation, migration and survival. Nowadays, the only possibility of cure for MTC patients consists of total thyroidectomy associated with lymph node dissection. Based on the knowledge of the pathogenic mechanisms of MTC, new drugs have been developed in attempt to control metastatic disease. Of these, the small-molecule tyrosine kinase inhibitors (TKIs) represent one of the most promising agents for MTC treatment and clinical trials have shown encouraging results. Hopefully, the cumulative knowledge about the targets of action of these drugs as well as TKI-associated side effects will help on choosing the best therapeutic approach in order to enhance its benefits.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoporpt_BR
dc.rightsOpen Accessen
dc.subjectEndocrinologiapt_BR
dc.subjectMedullary Thyroid Carcinomaen
dc.subjectFeocromocitomapt_BR
dc.subjectTyrosine kinase inhibitorsen
dc.subjectIndutores da angiogênesept_BR
dc.subjectProtooncogene RETen
dc.titleO papel dos marcadores de angiogênese no feocromocitomapt_BR
dc.typeDissertaçãopt_BR
dc.identifier.nrb000897055pt_BR
dc.degree.grantorUniversidade Federal do Rio Grande do Sulpt_BR
dc.degree.departmentFaculdade de Medicinapt_BR
dc.degree.programPrograma de Pós-Graduação em Ciências Médicas: Endocrinologiapt_BR
dc.degree.localPorto Alegre, BR-RSpt_BR
dc.degree.date2013pt_BR
dc.degree.levelmestradopt_BR


Ficheros en el ítem

Thumbnail
   

Este ítem está licenciado en la Creative Commons License

Mostrar el registro sencillo del ítem